Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Not refereed |
Title | Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy. |
Journal | Formal name:Cancer Chemotherapy and Phartmacology |
Publisher | Springer |
Volume, Number, Page | 80(1),pp.81-90 |
Papers・Author | Mizushima Tsunekazu, Fukunaga Mutsumi, Sueda Toshinori, Ikeda Masataka, Kato Takeshi, Kim Ho Min, Kudo Toshihiro, Murata Kohei, Nishimura Junichi, Hata Taishi, Matsuda Chu, Yamamoto Hirofumi, Doki Yuichiro, Mori Masaki |
Publication date | 2017/06 |